GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis

  • Katya E. Sosnovski
  • , Tzipi Braun
  • , Amnon Amir
  • , Danielle Moshel
  • , Marina Benshoshan
  • , Kelli L. Vandussen
  • , Nina Levhar
  • , Haya Abbas-Egbariya
  • , Katia Beider
  • , Rakefet Ben-Yishay
  • , Syed Asad Ali
  • , Sean R. Moore
  • , Subra Kugathasan
  • , Ifat Abramovich
  • , Efrat Glick Saar
  • , Batya Weiss
  • , Iris Barshack
  • , Eyal Gottlieb
  • , Tamar Geiger
  • , Shomron Ben-Horin
  • Igor Ulitsky, Jeffrey S. Hyams, Lee A. Denson, Yael Haberman

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

Background and Aims: Widespread dysregulation of long non-coding RNAs [lncRNAs] including a reduction in GATA6-AS1 was noted in inflammatory bowel disease [IBD]. We previously reported a prominent inhibition of epithelial mitochondrial functions in ulcerative colitis [UC]. However, the connection between reduction of GATA6-AS1 expression and attenuated epithelial mitochondrial functions was not defined. Methods: Mucosal transcriptomics was used to conform GATA6-AS1 reduction in several treatment-naïve independent human cohorts [n=673]. RNA pull-down followed by mass spectrometry was used to determine the GATA6-AS1 interactome. Metabolomics and mitochondrial respiration following GATA6-AS1 silencing in Caco-2 cells were used to elaborate on GATA6-AS1 functions. Results: GATA6-AS1 showed predominant expression in gut epithelia using single cell datasets. GATA6-AS1 levels were reduced in Crohn's disease [CD] ileum and UC rectum in independent cohorts. Reduced GATA6-AS1 lncRNA was further linked to a more severe UC form, and to a less favourable UC course. The GATA6-AS1 interactome showed robust enrichment for mitochondrial proteins, and included TGM2, an autoantigen in coeliac disease that is induced in UC, CD and coeliac disease, in contrast to GATA6-AS1 reduction in these cohorts. GATA6-AS1 silencing resulted in induction of TGM2, and this was coupled with a reduction in mitochondrial membrane potential and mitochondrial respiration, as well as in a reduction of metabolites linked to aerobic respiration relevant to mucosal inflammation. TGM2 knockdown in GATA6-AS1-deficient cells rescued mitochondrial respiration. Conclusions: GATA6-AS1 levels are reduced in UC, CD and coeliac disease, and in more severe UC forms. We highlight GATA6-AS1 as a target regulating epithelial mitochondrial functions, potentially through controlling TGM2 levels.

Original languageEnglish (US)
Pages (from-to)960-971
Number of pages12
JournalJournal of Crohn's and Colitis
Volume17
Issue number6
DOIs
Publication statusPublished - 1 Jun 2023

Keywords

  • GATA6-AS1 long non-coding RNA
  • inflammatory bowel disease
  • mitochondria

Fingerprint

Dive into the research topics of 'GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis'. Together they form a unique fingerprint.

Cite this